Abstract

BackgroundSmoking cessation is one of the most effective secondary prevention measures after acute myocardial infarction (AMI). However, around 50% of smokers do not quit smoking after AMI. The aim of the present study is to estimate the proportion of patients quitting smoking and to identify determinants of persistent smoking after AMI in a region with increased cardiovascular mortality. We also assessed the time of smoking cessation after AMI.MethodsWe used follow-up data of patients registered with the Regional Myocardial Infarction Registry in Saxony-Anhalt (RHESA) in Germany. We assessed smoking status and determinants of persistent smoking six weeks after discharge from hospital after AMI. Information on smoking, sociodemographic characteristics, risk factors for AMI, experienced symptoms of AMI, and clinical care were gathered in a computer-assisted telephone interview and questionnaires filled out by study subjects and physicians or study nurses.ResultsOut of 372 smokers at the time of AMI, 191 (51.3%) reported that they quit smoking within six weeks after discharge from hospital after AMI. Strongest determinant of persistent smoking was a previous AMI before the current one (OR = 2.19, 95%CI 1.10–4.38) and strongest determinants of smoking cessation were experiencing complications in the hospital (0.37, 95%CI 0.12–1.12) and having a life partner (0.56, 95%CI 0.34–0.95). Most individuals who stopped smoking did so during the initial stay in the hospital, before the cardiac rehabilitation (CR).ConclusionsPersistent smoking after AMI and its determinants were similar in our region to previous studies. CR cannot be viewed as determinant of smoking cessation – more likely the same teachable moment induces behavioural change with regard to smoking and participation in CR.

Highlights

  • Smoking cessation is one of the most effective secondary prevention measures after acute myocardial infarction (AMI)

  • Study design and setting RHESA-CARE 1 and 3 (RC1, RHESA-care 3 (RC3)) are follow-up studies of patients who agreed to participate in the Regional Myocardial Infarction Registry of Saxony-Anhalt (RHES A) [2, 16]

  • Since RHESA continued to recruit patients beyond the end of the RHESA-care 1 (RC1) study, we conducted an additional follow-up to include patients registered after January 2018, but included all patients registered with RHESA between June 2013 and January 2019

Read more

Summary

Introduction

Smoking cessation is one of the most effective secondary prevention measures after acute myocardial infarction (AMI). The aim of the present study is to estimate the proportion of patients quitting smoking and to identify determinants of persistent smoking after AMI in a region with increased cardiovascular mortality. Saxony-Anhalt has been one of the federal states in Germany with the highest incidence and mortality of acute myocardial infarction (AMI) [1]. One of the most effective secondary prevention measures after AMI is smoking cessation [4]. A metaanalysis of twelve studies with a follow-up from two to ten years after AMI reported a 0.54 (95% CI 0.46–0.62) times reduced overall mortality for quitters compared to those who continued smoking [5]. In Würzburg, the German study centre of that study, the quit rate was 47%

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call